Addictive Behaviors is now accepting submissions for a special issue, Prevention and Treatment of Opioid Overdose and Opioid-Use Disorders. Papers may include epidemiological, laboratory-based, or community-based research on prevention and/or treatment of opioid overdose, misuse…
West Virginia is in the midst of an unprecedented heroin and opioid epidemic that is disrupting the lives of not only individuals and families, but also entire communities and regions. A recent white paper developed by the…
The Substance Abuse and Mental Health Services Administration (SAMHSA) is accepting applications for the Targeted Capacity Expansion-HIV Program: Substance Use Disorder Treatment for Racial/Ethnic Minority Populations at High Risk for HIV/AIDS totaling up to $142.9…
The Winter 2017 issue of NACCHO Exchange, “On the Frontlines: Local Public Health versus America’s Opioid Epidemic,” is now available for free download in the NACCHO Bookstore. Opioid addiction and misuse have affected inner city, suburban, and rural communities,…
This week, January 23–29, 2017, marks National Drug and Alcohol Facts Week. Although this annual observance is aimed at engaging teens in events that debunk myths about drugs and alcohol, NACCHO is instead taking this…
MATx is a new mobile app to help health care practitioners provide evidence-based medication-assisted treatment (MAT) for opioid use disorders. Developed by the Substance Abuse and Mental Health Services Administration (SAMHSA), the app’s features include: Information…
From 2014 to 2015, the death rate from synthetic opioids other than methadone, which includes fentanyl, increased by 72.2%, and heroin death rates increased by 20.6%. Rates of death involving heroin and synthetic opioids other…
On November 17, 2016, the Office of the Surgeon General released Facing Addiction in America: The Surgeon General’s Report on Alcohol, Drugs & Health. This historic, first-ever report was unveiled at Facing Addiction in America: A National Summit.…
Last week, the United States Surgeon General, Vivek H. Murthy, M.D., M.B.A., released a letter to more than 2.3 million health care practitioners and public health leaders across the country to seek help in addressing the prescription…
The FDA approved NARCAN® (naloxone hydrochloride) Nasal Spray for the emergency treatment of known or suspected opioid overdose. In 2013, opioid overdose related deaths claimed over 24,500 lives and this number continues to grow. NARCAN Nasal…